Evidence map›Paper›PMID 40842583›Full record

SynthesisFrontiers in oncology2025

Barriers to cancer screening uptake and approaches to overcome them: a systematic literature review.

R Aguiar-Ibáñez, Ypv Mbous, Sugandh Sharma, R Chakali, E Chawla

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. The Missing Dimension in Cancer Education: Developmental Meaning-Making and the Expert's Illusion of Symmetry.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Lung Cancer Screening and Prevention: Beyond Conventional Strategies in a Rapidly Changing Global Milieu.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

R Aguiar-IbáñezMerck Canada Inc., Kirkland, QC, Canada.
Ypv MbousMerck & Co., Inc., Rahway, NJ, United States.
Sugandh SharmaParexel International, Chandigarh, India.
R ChakaliParexel International, Bengaluru, India.
E ChawlaParexel International, Mohali, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Cancer screening programs play a crucial role in early detection, improving survival rates and reducing the burden of advanced cancer. However, uptake remains inconsistent due to multifaceted barriers. This systematic review aimed to identify factors that impact cancer screening uptake across multiple tumor types and interventions to overcome barriers to cancer screening uptake. Methods: A systematic literature review (SLR) was conducted using Embase Results: Overall, 811 studies were identified from the SLR that reported factors influencing the uptake of screening programs, with 658 studies covering screening programs for breast, cervical, lung, colorectal, gastric and prostate cancers. Barriers to cancer screening included: being unmarried, experiencing higher deprivation, lower socioeconomic status and rural living conditions. Facilitators to cancer screening included: older age, poor perception of health, previous cancer history, family history of cancer, previous cancer screening history, having knowledge of the disease, positive attitudes to screening, perceived cancer risk, higher education level, having children, higher income, higher socioeconomic status, having health insurance, urban residence, having access to care, and recommendations for screening by primary care physicians. Mixed findings were identified for race and ethnicity, employment and smoking status. Targeted educational programs were the most suggested strategy to overcome barriers to cancer screening uptake. Conclusion: Barriers to cancer screening across multiple tumor types are complex, spanning demographic and patient-level factors, social and economic factors, provider and community challenges, and access to health care. While certain barriers are shared across tumor types, others are unique, reflecting the specific requirements of screening for different tumors. Addressing these barriers requires multi-level strategies that integrate both universal and cancer-specific approaches. Targeted interventions and supportive policies can increase screening participation, facilitate earlier cancer diagnosis, and reduce disparities in cancer outcomes.

Indexed as

barrierscancer screeningfacilitatorspreventative healthcarepublic healthscreening interventionscreening uptake

Identifiers

PMID40842583
PMCPMC12364675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.